NeoGenomics Stock (NASDAQ: NEO) stock price, news, charts, stock research, profile.
|Vol / Avg.716.712K / 925.461K||Mkt Cap2.353B|
|Day Range18.335 - 18.970||52 Wk Range8.710 - 20.540|
|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
|2023-11-08||Morgan Stanley||Tejas Savant||Maintains||Equal-WeightEqual-Weight||Raises||16.00||17.00|
|2023-10-24||Morgan Stanley||Tejas Savant||Maintains||Equal-WeightEqual-Weight||Lowers||18.00||16.00|
|2023-10-23||Goldman Sachs||Matthew Sykes||Maintains||BuyBuy||Lowers||19.00||17.00|
|Ticker||Company||Chg %||Mkt Cap|
|HIMS||Hims & Hers Health||-1.24%||1.9B|
You can purchase shares of NeoGenomics (NASDAQ: NEO) through any online brokerage.
The latest price target for NeoGenomics (NASDAQ: NEO) was reported by Morgan Stanley on Wednesday, November 8, 2023. The analyst firm set a price target for 17.00 expecting NEO to fall to within 12 months (a possible -7.91% downside). 25 analyst firms have reported ratings in the last year.
The stock price for NeoGenomics (NASDAQ: NEO) is $18.46 last updated December 5, 2023 at 10:46 PM UTC.
There is no dividend information for NeoGenomics.
NeoGenomics’s Q4 earnings are confirmed for Thursday, February 22, 2024.
There is no upcoming split for NeoGenomics.
NeoGenomics is in the Health Care sector and Health Care Providers & Services industry. They are listed on the NASDAQ.